Albuked: payments to doctors
Payments that named Albuked as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $369K
- Providers
- 1,372
- Transactions
- 2,042
- Average per transaction
- $181
The per-transaction average — $181 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 1,372 providers the average total is $269, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Kedrion Biopharma, Inc. | $267,557 | 72.5% |
| Kedrion Biopharma Inc. | $101,328 | 27.5% |